Connect with us
Twitter Files reveals Pfizer board member's attempt to suppress debate on Covid vaccines Twitter Files reveals Pfizer board member's attempt to suppress debate on Covid vaccines

News

Twitter Files reveals Pfizer board member’s attempt to suppress debate on Covid vaccines

Published

on

In another installment of the Twitter Files released on Monday, screenshots of an email conversation between Scott Gottlieb, a board member at Pfizer, with Todd O’Boyle, a senior manager of public policy at Twitter.

Alex Berenson, a former reporter for the New York Times, shared this installment. Berenson noted that Gottlieb “used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, including from a fellow head of the US FDA.”

https://twitter.com/elonmusk/status/1612544141866729473

Gottlieb shared a tweet by Doctor Brett Giroir that said that the Covid19 natural immunity was superior to vaccine immunity by a lot.

“This is the kind of stuff that’s corrosive. Here he draws a sweeping conclusion off a single retrospective study in Israel that hasn’t been peer-reviewed. But this tweet will end up going viral and driving news coverage,” Gottlieb said.

Advertisement

Credit: Alex Berenson

Berenson noted that he found the email while searching records while at Twitter last week. He found that through Jira, Twitter’s internal system for managing complaints, O’Boyle forwarded Gottlieb’s email to the Twitter Strategic Response team, which was responsible for handling concerns for the platform’s most important employees and users.

“Please see this report from the former FDA commissioner,” O’Boyle wrote. Berenson noted that O’Boyle failed to mention that Gottlieb was a Pfizer board member “with a financial interest in pushing mRNA shots.”

Although a Strategic Response analyst found that the tweet did not violate any of Twitter’s misinformation rules, the tweet ended up being flagged as misleading. Berenson pointed out that the tweet remains flagged despite several studies confirming the accuracy of Girior’s tweet.

 

Credit: Alex Berenson

 

Following that, Gottlieb complained about a tweet from Justin Hart, whose Twitter following was over 100,000. Berenson pointed out that although Gottlieb’s objection to Hart’s tweet, which mentioned a viral pathogen with a child mortality rate of <>0% wasn’t clear. However, he added, Pfizer should soon be approved for children ages 5 to 11. Again, O’Boyle didn’t mention Gottlieb’s connection with Pfizer when forwarding the report.

Twitter didn’t act on Gottlieb’s request this time. Berenson also noted that Gottlieb was “pressing Twitter to act against me.” He added that Gottlieb’s action was part of a larger one that included the Biden White House and Andrew Slavitt. He said the group worked publicly and privately to pressure Twitter until it had no option but to ban him.

Advertisement

“I will have more to say about my own case and will be suing the White House, Slavitt, Gottlieb, and Pfizer shortly,” Berenson wrote.

The Twitter Files is continuing to be released, and you can read our articles on them here.

Your feedback is welcome. If you have any comments or concerns or see a typo, you can email me at johnna@teslarati.com. You can also reach me on Twitter at @JohnnaCrider1.

Teslarati is now on TikTok. Follow us for interactive news & more. Teslarati is now on TikTok. Follow us for interactive news & more. You can also follow Teslarati on LinkedInTwitter, Instagram, and Facebook.

Advertisement
Advertisement
Comments

Elon Musk

Tesla analysts believe Musk and Trump feud will pass

Tesla CEO Elon Musk and U.S. President Donald Trump’s feud shall pass, several bulls say.

Published

on

The White House, Public domain, via Wikimedia Commons
President Donald J. Trump purchases a Tesla on the South Lawn, Tuesday, March 11, 2025. (Official White House Photo by Molly Riley)

Tesla analysts are breaking down the current feud between CEO Elon Musk and U.S. President Donald Trump, as the two continue to disagree on the “Big Beautiful Bill” and its impact on the country’s national debt.

Musk, who headed the Department of Government Efficiency (DOGE) under the Trump Administration, left his post in May. Soon thereafter, he and President Trump entered a very public and verbal disagreement, where things turned sour. They reconciled to an extent, and things seemed to be in the past.

However, the second disagreement between the two started on Monday, as Musk continued to push back on the “Big Beautiful Bill” that the Trump administration is attempting to sign into law. It would, by Musk’s estimation, increase spending and reverse the work DOGE did to trim the deficit.

President Trump has hinted that DOGE could be “the monster” that “eats Elon,” threatening to end the subsidies that SpaceX and Tesla receive. Musk has not been opposed to ending government subsidies for companies, including his own, as long as they are all abolished.

How Tesla could benefit from the ‘Big Beautiful Bill’ that axes EV subsidies

Despite this contentious back-and-forth between the two, analysts are sharing their opinions now, and a few of the more bullish Tesla observers are convinced that this feud will pass, Trump and Musk will resolve their differences as they have before, and things will return to normal.

ARK Invest’s Cathie Wood said this morning that the feud between Musk and Trump is another example of “this too shall pass:”

Advertisement

Additionally, Wedbush’s Dan Ives, in a note to investors this morning, said that the situation “will settle:”

“We believe this situation will settle and at the end of the day Musk needs Trump and Trump needs Musk given the AI Arms Race going on between the US and China. The jabs between Musk and Trump will continue as the Budget rolls through Congress but Tesla investors want Musk to focus on driving Tesla and stop this political angle…which has turned into a life of its own in a roller coaster ride since the November elections.”

Advertisement

Tesla shares are down about 5 percent at 3:10 p.m. on the East Coast.

Continue Reading

Elon Musk

Tesla scrambles after Musk sidekick exit, CEO takes over sales

Tesla CEO Elon Musk is reportedly overseeing sales in North America and Europe, Bloomberg reports.

Published

on

Credit: Tesla

Tesla scrambled its executives around following the exit of CEO Elon Musk’s sidekick last week, Omead Afshar. Afshar was relieved of his duties as Head of Sales for both North America and Europe.

Bloomberg is reporting that Musk is now overseeing both regions for sales, according to sources familiar with the matter. Afshar left the company last week, likely due to slow sales in both markets, ending a seven-year term with the electric automaker.

Tesla’s Omead Afshar, known as Elon Musk’s right-hand man, leaves company: reports

Afshar was promoted to the role late last year as Musk was becoming more involved in the road to the White House with President Donald Trump.

Afshar, whose LinkedIn account stated he was working within the “Office of the CEO,” was known as Musk’s right-hand man for years.

Advertisement

Additionally, Tom Zhu, currently the Senior Vice President of Automotive at Tesla, will oversee sales in Asia, according to the report.

It is a scramble by Tesla to get the company’s proven executives over the pain points the automaker has found halfway through the year. Sales are looking to be close to the 1.8 million vehicles the company delivered in both of the past two years.

Tesla is pivoting to pay more attention to the struggling automotive sales that it has felt over the past six months. Although it is still performing well and is the best-selling EV maker by a long way, it is struggling to find growth despite redesigning its vehicles and launching new tech and improvements within them.

The company is also looking to focus more on its deployment of autonomous tech, especially as it recently launched its Robotaxi platform in Austin just over a week ago.

Tesla officially launches Robotaxi service with no driver

Advertisement

However, while this is the long-term catalyst for Tesla, sales still need some work, and it appears the company’s strategy is to put its biggest guns on its biggest problems.

Continue Reading

News

Tesla upgrades Model 3 and Model Y in China, hikes price for long-range sedan

Tesla’s long-range Model 3 now comes with a higher CLTC-rated range of 753 km (468 miles).

Published

on

Credit: Tesla China

Tesla has rolled out a series of quiet upgrades to its Model 3 and Model Y in China, enhancing range and performance for long-range variants. The updates come with a price hike for the Model 3 Long Range All-Wheel Drive, which now costs RMB 285,500 (about $39,300), up RMB 10,000 ($1,400) from the previous price.

Model 3 gets acceleration boost, extended range

Tesla’s long-range Model 3 now comes with a higher CLTC-rated range of 753 km (468 miles), up from 713 km (443 miles), and a faster 0–100 km/h acceleration time of 3.8 seconds, down from 4.4 seconds. These changes suggest that Tesla has bundled the previously optional Acceleration Boost for the Model 3, once priced at RMB 14,100 ($1,968), as a standard feature.

Delivery wait times for the long-range Model 3 have also been shortened, from 3–5 weeks to just 1–3 weeks, as per CNEV Post. No changes were made to the entry-level RWD or Performance versions, which retain their RMB 235,500 and RMB 339,500 price points, respectively. Wait times for those trims also remain at 1–3 weeks and 8–10 weeks.

Model Y range increases, pricing holds steady

The Model Y Long Range has also seen its CLTC-rated range increase from 719 km (447 miles) to 750 km (466 miles), though its price remains unchanged at RMB 313,500 ($43,759). The model maintains a 0–100 km/h time of 4.3 seconds.

Tesla also updated delivery times for the Model Y lineup. The Long Range variant now shows a wait time of 1–3 weeks, an improvement from the previous 3–5 weeks. The entry-level RWD version maintained its starting price of RMB 263,500, though its delivery window is now shorter at 2–4 weeks.

Advertisement

Tesla continues to offer several purchase incentives in China, including an RMB 8,000 discount for select paint options, an RMB 8,000 insurance subsidy, and five years of interest-free financing for eligible variants.

Continue Reading

Trending